Ironwood Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good morning. I'm David Lebowitz, one of the biotechnology analysts at Morgan Stanley. Before I get started, I have to go through the requisite disclosures. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
I'd like to welcome you all this morning to the Morgan Stanley 18th Annual Global Healthcare Conference. In this session, I have with us from Ironwood Pharmaceuticals, CEO, Mark Mallon; and President, Tom McCourt. This is a company that's been around for a while. They are -- they sell a drug called LINZESS for the treatment of constipation. And I guess before
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |